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Analysis of Organic Acids and Acylglycines
for the Diagnosis of Related Inborn Errors
of Metabolism by GC- and HPLC-MS
Giancarlo la Marca and Cristiano Rizzo
Abstract
The analysis of organic acids in urine is commonly included in routine procedures for detecting many
inborn errors of metabolism. Many analytical methods allow for both qualitative and quantitative deter-
mination of organic acids, mainly in urine but also in plasma, serum, whole blood, amniotic fluid, and
cerebrospinal fluid. Liquid–liquid extraction and solid-phase extraction using anion exchange or silica
columns are commonly employed approaches for sample treatment. Before analysis can be carried out
using gas chromatography-mass spectrometry, organic acids must be converted into more thermally sta-
ble, volatile, and chemically inert forms, mainly trimethylsilyl ethers, esters, or methyl esters.
Key words: Organic acids, inborn errors of metabolism, gas chromatography-mass spectrometry,
organic acidurias.
1. Introduction
Organic acids are small molecules continuously produced,
metabolized, and excreted by healthy individuals, as well as by
those in abnormal states. Their origins include the metabolic
pathways of amino acids, carbohydrates, lipids, and steroids, as
well as drug metabolism, bacterial decomposition of food in the
intestine, artifacts due to storage, sample preparation, and analysis
of the sample (see Note 1). A list of the most characteristic diag-
nostic organic acids and their associated disorders is reported in
Table 4.1. To date, by the analytical methodologies available,
more than 250 different compounds (mainly organic acids) and
glycine conjugates can be identified in the urine of a normal
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Table 4.1
Characteristic organic acids profile in metabolic disorders
Disorders Metabolites
Amino acid disorders
Maple syrup urine disease 2-Keto-isocaproic acid
2-Keto-isovaleric acid
2-Keto-3-methylvaleric acid
2-Hydroxy-isocaproic acid
2-Hydroxy-isovaleric acid
2-Hydroxy-3-methylvaleric acid
Tyrosinemia type I 4-Hydroxy-phenyllactic acid
Succinylacetone
4-Hydroxy-phenylpyruvic acid
Tyrosinemia type II 4 Hydroxy-phenyllactic acid
4-Hydroxy-phenylpyruvic acid
Phenylketonuria Phenyllactic acid
Phenylpyruvic acid
Mandelic acid di-TMS
Organic acidurias
Isovaleric acidemia 3-Hydroxy-isovaleric acid
Isovalerylglycine
Isovalerylglutamic acid
3-Methylcrotonyl-CoA carboxylase deficiency 3-Hydroxy-isovaleric acid
3-Methylcrotonylglycine
Multiple carboxylase deficiency 3-Hydroxy-isovaleric acid
Lactic acid
Methylcitric acid
3-Hydroxy-propionic acid
3-Methylcrotonylglycine
3-Hydroxy-3-methylglutaric aciduria 3-Hydroxy-3-methylglutaric acid
3-Methylglutaconic acid
3-Methylglutaric acid
3-Hydroxy-isovaleric acid
3-Methylcrotonylglycine
3-Methylglutaconic aciduria 3-Methylglutaconic acid
3-Methylglutaric acid
3-Ketothiolase deficiency 2-Methyl-3-hydroxy-butyric acid
2-Methyl-acetoacetic acid
3-Hydroxy-butyric acid
Tiglylglycine
2-Methylbutyryl-CoA dehydrogenase deficiency 2-Methylbutyrylglycine
2-Methyl-3-hydroxy-butyryl-CoA dehydrogenase deficiency 2-Methyl-3-hydroxy-butyric acid
Tiglylglycine
Propionic acidemia 3-Hydroxy-propionic acid
Methylcitric acid
Propionylglycine
Tiglylglycine
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Table 4.1
(continued)
Disorders Metabolites
Methylmalonic aciduria Methylmalonic acid
3-Hydroxy-propionic acid
Methylcitric acid
Glutaric aciduria type I Glutaric acid
3-Hydroxy-glutaric acid
Glutaconic acid
Beta-oxidation fatty acid defects
Glutaric aciduria type II Glutaric acid
Ethylmalonic acid
Adipic acid
Suberic acid
2-Hydroxy-glutaric acid
Isovalerylglycine
Isobutyrylglycine
2-Methylbutyrylglycine
Short chain acyl-CoA dehydrogenase deficiency Ethylmalonic acid
Butyrylglycine
Methylsuccinic acid
Adipic acid
Suberic acid
Sebacic acid
Medium chain acyl-CoA dehydrogenase deficiency 5-Hydroxy-hexanoic acid
7-Hydroxy-octanoic acid
Adipic acid
Suberic acid
Sebacic acid
Octanedioic acid
Decanedioic acid
Hexanoylglycine
Phenylpropionylglicine
Suberylglycine
Very long-chain acyl-CoA dehydrogenase deficiency Suberic acid
Sebacic acid
Long-chain 3-hydroxy-acyl-CoA dehydrogenase deficiency Adipic acid
Mitochondrial trifunctional protein deficiency Suberic acid
Sebacic acid
2-Hydroxy-adipic acid
3-Hydroxy-adipic acid
3-Hydroxy-octenedioic acid
3-Hydroxy-suberic acid
3-Hydroxy-decanedioic acid
3-Hydroxy-sebacic acid
3-Hydroxy-dodecenedioic acid
3-Hydroxy-dodecanedioic acid
3-Hydroxy-tetradecenedioic acid
3-Hydroxy-tetradecanedioic acid
Short-chain 3-hydroxy-acyl-CoA dehydrogenase deficiency 3,4-Dihydroxy-butyric acid
3-Hydroxy-glutaric acid
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Table 4.1
(continued)
Disorders Metabolites
Translocase deficiency Adipic acid
Suberic acid
Sebacic acid
Dodecanedioic aid
Tetradecanedioic acid
Urea cycle defects
HHH syndrome, OTCD, argininemia Orotic acid
Citrullinemia, argininosuccinic aciduria Uracil
Carbamoyl phosphate synthetase deficiency 3-Methylglutaconic acid
Carbohydrate metabolism
Fructose 1,6-bisphosphatase deficiency Lactic acid
Glycerol
Glycerol 3-phosphate
Glycogenosis type I Lactic acid
3-Methylglutaconic acid
3-Metylglutaric acid
Galactosemia 4-Hydroxy-phenyl-lactic acid
Hereditary fructose intolerance 4-Hydroxy-phenyl-lactic acid
Pyruvate dehydrogenase (subunit E3) deficiency Lactic acid
2-Ketoglutaric acid
Succinic acid
Malic acid
2-Keto-isocaproic acid
2-Keto-isovaleric acid
2-Keto-3-methylvaleric acid
2-Hydroxy-isocaproic acid
2-Hydroxy-isovaleric acid
2-Hydroxy-3-methylvaleric acid
Pyruvate carboxylase deficiency Lactic acid
Pyruvic acid
Succinic acid
Malic acid
Fumaric acid
Miscellaneous
Lactic acidosis Lactic acid
Pyruvic acid
2-Hydroxy-butyric acid
2-Hydroxy-isobutyric acid
4-Hydroxy-phenyl-lactic acid
Hyperoxaluria type I Glycolic acid
Oxalic acid
Hyperoxaluria type II Oxalic acid
Glyceric acid
D-glyceric aciduria D-glyceric acid
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Table 4.1
(continued)
Disorders Metabolites
Glycerol kinase deficiency Glycerol
3-Hydroxy-isobutyric aciduria 3-Hydroxy-isobutyric acid
Fumaric aciduria Fumaric acid
Malonic aciduria Malonic acid
Methylmalonic acid
Succinic acid
Mevalonic aciduria Mevalonic acid
Alkaptonuria Homogentisic acid
Canavan disease N-acetylaspartic acid
Acylase I deficiency N-acetyl-alanine
N-acetylaspartic acid
N-acetylglutamic acid
N-acetyl-isoleucine
N-acetyl-methionine
N-acetyl-serine
N-acetyl-valine
Pyroglutamic aciduria Pyroglutamic acid
Xanthurenic aciduria Xanthurenic acid
Peroxisomal biogenesis disorders 3,6-Epoxyoctanedioc acid
3,6-Epoxydecanedioc acid
3,6-Epoxydodecanedioc acid
3,6-Epoxytetradecanedioc acid
2-Hydroxy-sebacic acid
4-Hydroxy-phenyllactic acid
Adipic acid
Suberic acid
Sebacic acid
Formiminoglutamic aciduria Hydantoin-3-hydroxy-propionic acid
2-Hydroxy-glutaric aciduria 2-Hydroxy-glutaric acid
Aromatic L-amino acid decarboxylase deficiency Vanyllactic acid
Dihydropyrimidine dehydrogenase deficiency Thymine
Uracil
Molybdenum cofactor deficiency Xanthine
individual (1), although a great variability due to age and diet
occurs (2). More than 70 inborn errors of metabolism are known
to yield a characteristic urinary organic acids pattern, which is
essential for diagnosis and follow-up (3). Organic acids can be
detected in many biological matrices (e.g., blood, plasma, serum,
amniotic fluid, and cerebrospinal fluid), but urine is the best fluid.
This is mainly due to the fact that organic acids are concentrated
in the urine by the kidneys, and this matrix contains very small
quantities of proteins, reducing potential drawbacks during sam-
ple analysis.
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There are three main steps for the determination of urinary
organic acids: (1) oximation; (2) extraction procedures: liquid–
liquid extraction or ion-exchange chromatography or solid-phase
extraction; (3) derivatization (usually silylation) followed by gas
chromatography with mass detection in scan and/or single ion
monitoring modes data acquisition. In 2002, Pitt and colleagues
(4) reported a new tandem mass spectrometry (MS/MS)-based
method to detect some organic acids and acylglycines in urine
with a simple dilution of sample by mobile phase followed by
direct injection into the mass spectrometer. In 2006, Rebollido
and colleagues proposed a modified Pitt method as a neonatal
screening tool for the detection of organic acids, acylglycines,
acylcarnitines, and amino acids from urine spotted on filter
paper (5).
Herein, we describe in detail how to perform the analysis of
organic acids and acylglycines in urine for the biochemical diag-
nosis of organic acidemias.
2. Materials
2.1. Reagent
Preparation for
Picrate
Determination of
Creatinine
All reagents (Siemens Healthcare Diagnostics Inc., Newark, NJ)
are dissolved in water and ready to use and are of reagent grade
unless stated otherwise. Their storage temperature is 2–8◦C.
These reagents are delivered and mixed automatically by the
Dimension Chemistry System during the determination of cre-
atinine.
1. Lithium picrate 25 mM.
2. Sodium hydroxide 100 mM.
3. Potassium ferricyanide 0.13 mM.
2.2. Solvents,
Standards, and
Reagents (See
Note 1)
All solvents are high-purity chromatography grade.
1. Ethyl acetate.
2. Pyridine.
3 Hydroxyl chloride acid, 30%.
4. Methanol.
5. N-butanol.
6. Formic acid.
7. Acetic acid.
8. Diethyl ether.
9. Ba(OH)2.
10. H2SO4.
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11. Hydroxylamine hydroxychloride (25 g/L), dissolved in
pyridine.
12. Stock solutions (10 mM) of each organic acid (Sigma-
Aldrich, St. Louis, MO) are prepared in water or methanol.
a. Glycolic acid.
b. Lactic acid.
c. 3-Hydroxy-propionic acid.
d. 3-Hydroxy-butyric acid.
e. 4-Hydroxy-butyric acid.
f. 2-Hydroxy-butyric acid.
g. Glyceric acid.
h. Fumaric acid.
i. Maleic acid.
j. 3-Hydroxy-isovaleric acid.
k. 2-Hydroxy-isovaleric acid.
l. Succinic acid.
m. Methylmalonic acid.
n. Glutaric acid.
o. Ethylmalonic acid.
p. Methylsuccinic acid.
q. Phosphoethanolamine.
r. 3-Methylglutaconic acid.
s. 2-Ketoglutaric acid.
t. 3-Methylglutaric acid.
u. Adipic acid.
v. 2-Hydroxy-glutaric acid.
w. Mevalonic acid.
x. 3-Hydroxy-glutaric acid.
y. 4-Hydroxy-phenylacetic acid.
z. Succinylacetone.
aa. 3-Hydroxy-3-methylglutaric acid.
bb. Homogentisic acid.
cc. Suberic acid.
dd. N-acetylaspartic acid.
ee. Homovanillic acid.
ff. 4-Hydroxy-phenylacetic acid.
gg. Sulfocysteine.
hh. Sialic acid.
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ii. Uracil.
jj. Thymine.
kk. Xanthine.
ll. Orotic acid.
mm. Uric acid.
13. Acylglycines were synthesized and purchased from
Dr. H. Ten Brink (Academic Medical Hospital, the Nether-
lands). Stock solutions (10 mM) of acylglycines are pre-
pared in water or methanol.
a. Propionylglycine.
b. Butyrylglycine.
c. Isobutyrylglycine.
d. 3-Methylcrotonylglycine.
e. Tiglylglycine.
f. Methylbutyrylglycine.
g. Isovalerylglycine.
h. Hexanoylglycine.
i. 3-Phenylpropionylglycine.
j. Suberylglycine.
14. Stock solutions (10 mM) of isotopically labeled and unla-
beled internal standards are prepared in water or methanol.
The storage temperature of the internal standards is –20◦C.
Under these conditions, the stability of the standard solu-
tions is at least 6 months.
a. Tricarballylic acid (TCA) (Sigma-Aldrich).
b. 2-Oxocaproic acid (OA) (Sigma-Aldrich).
c. 2-Phenylbutyric acid (PBA) (Sigma-Aldrich).
d. Dimethylmalonic acid (DMMA) (Sigma-Aldrich).
e. Tropic acid (TPA) (Sigma-Aldrich).
f. Pentadecanoic acid (PDA) (Sigma-Aldrich).
g. 2H3-methylmalonic acid (Cambridge Isotopes Labora-
tories, Andover, MA).
h. 2H3-3-hydroxy-isovaleric acid (C.D.N. Isotopes,
Pointe-Claire, Quebec, Canada).
i. 13C6-adipic acid (Cambridge Isotopes Laboratories).
j. 2H3-3-hydroxy-3-methylglutaric acid (C.D.N. Iso-
topes).
k. 2H3-acetylaspartic acid (C.D.N. Isotopes).
l. 1,3 15N2-uric acid (Cambridge Isotopes Laboratories).
m. 15N2-uracil (C.D.N. Isotopes).
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n. 2H4-thymine (C.D.N. Isotopes).
o. 15N2-orotic acid (C.D.N. Isotopes).
p. 2H3-propionylglycine (Dr. H. Ten Brink, Academic
Medical Hospital, the Netherlands).
q. 2H3-hexanoylglycine (Dr. H. Ten Brink, Academic
Medical Hospital, the Netherlands).
15. Silylating reagents.
a. N,O-bis-(trimethylsilyl)trifluoroacetamide (BSTFA)
(Supelco, Bellefonte, PA).
b. N-methyl-N-trifluoroacetamide (MSTFA) (Supelco).
c. N,O-bis-(trimethylsilyl)acetamide (BSA) (Supelco).
d. N-methyl-N-(tert-butyldimethyl-
silyl)trifluoroacetimide (MTBSTFA) (Supelco).
2.3. Glassware 1. Extraction tubes (see Note 1): 8 mL screw-capped pyrex
glass tubes (14 × 100 mm) with Teflon-lined caps (Barcor-
word Scientific, Ltd., Stone Staff, UK).
2. GC-MS 2 mL glass vials (9 mm) and caps with siliconized
rubber septa (Chromacol, Ltd. Welwyn Garden City, UK)
(see Note 1).
2.4. Columns 1. Gas chromatography separation column: Agilent J&W
ULTRA2 (methyl siloxane 5% phenyl), 25 m × 0.20 mm ×
0.33 μm fused silica capillary column or an HP-5 ms (methyl
siloxane 5% phenyl), 25 m × 0.25 mm × 0.25 μm fused sil-
ica capillary column.
2.5. Internal
Standards for
Semiquantitative
and Quantitative
Determination of
Organic Acids and
Acylglycines in Urine
by GC-MS
A stock calibration solution containing 100 mg/L of each inter-
nal standard in ethanol/water (1:1, v/v) is made and stored at
4◦C or less (see Note 2).The final makeup volume of the work-
ing calibration solution is 50 μL; therefore, the concentration of
the working calibration solution is 1 μg/mol creatinine when the
added internal standard volume is 10 μL and 2 μg/mol creatinine
when the added internal standard volume is 20 μL.
1. Dimethylmalonic acid (DMMA). Working calibration
solution contains 10 μL of DMMA (100 mg/L) in
ethanol/water (1:1, v/v). Store at 4◦C or less.
2. Tropic acid (TA). Working calibration solution contains 20
μL of TA (100 mg/L) in aqueous solution. Store at 4◦C
or less.
3. Pentadecanoic acid (PDA). Working calibration solution
contains 20 μL of PDA (100 mg/L) in ethanol. Store at
4◦C or less.
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4. Tricarballylic acid (propane-1,2,3-tricarboxylic acid).
Working calibration solution contains 10 μL of tricar-
ballylic acid (100 mg/L) in aqueous solution. Store at 4◦C
or less.
5. 2-Phenylbutyric acid. Working calibration solution con-
tains 10 μL of a 2-phenylbutyric acid (100 mg/L) in aque-
ous solution. Store at 4◦C or less.
6. 2-Oxocaproic acid (2-oxohexanoic acid). Working cali-
bration solution contains 10 μL of a 2-oxocaproic acid
(100 mg/L) in aqueous solution. Store at 4◦C or
less.
7. 2H3-methylmalonic acid. Working calibration solution
contains 10 μL of 2H3-methylmalonic acid (100 mg/L)
in ethanol. Store at 4◦C or less.
8. 2H3-3-hydroxy-isovaleric acid. Working calibration solu-
tion contains 10 μL of 2H3-3-hydroxy-isovaleric acid
(100 mg/L) in ethanol. Store at 4◦C or less.
9. 13C6-adipic acid. Working calibration solution contains 10
μL of 13C6-adipic acid (100 mg/L) in ethanol. Store at
4◦C or less.
10. 2H3-3-hydroxy-3-methylglutaric acid. Working calibra-
tion solution contains 10 μL of 2H3-3-hydroxy-3-
methylglutaric acid (100 mg/L) in ethanol. Store at 4◦C
or less.
11. 2H3-acetylaspartic acid. Working calibration solution con-
tains 10 μL of 2H3-acetylaspartic acid (100 mg/L) in
ethanol. Store at 4◦C or less.
12. 2H3-propionylglycine. Working calibration solution con-
tains 20 μL of 2H3-propionylglycine (100 mg/L) in
ethanol. Store at 4◦C or less.
13. 2H3-hexanoylglycine. Working calibration solution con-
tains 20 μL of 2H3-hexanoylglycine (100 mg/L) in
ethanol. Store at 4◦C or less.
2.6. Internal
Standards and
Calibrators for
Semiquantitative
and Quantitative
Determination of
Organic Acids and
Acylglycines in Urine
by HPLC-MS/MS
A stock calibration solution containing 100 mg/L of each inter-
nal standard in ethanol is made and stored at 4◦C or less (see
Note 2). The final makeup volume of the working calibration
solution is 200 μL; therefore, the concentration of the working
calibration solution is 5 μg/mol creatinine when the added inter-
nal standard volume is 10 μL and 10 μg/mol creatinine when
the added internal standard volume is 20 μL.
1. 2H3-methylmalonic acid. Working calibration solution
contains 10 μL of 2H3-methylmalonic acid (100 mg/L)
in ethanol. Store at 4◦C or less.
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2. 2H3-3-hydroxy-isovaleric acid. Working calibration solu-
tion contains 10 μL of 2H3-3-hydroxy-isovaleric acid
(100 mg/L) in ethanol. Store at 4◦C or less.
3. 13C6-adipic acid. Working calibration solution contains 10
μL of 13C6-adipic acid (100 mg/L) in ethanol. Store at
4◦C or less.
4. 2H3-3-hydroxy-3-methylglutaric acid. Working calibra-
tion solution contains 10 μL of 2H3-3-hydroxy-3-
methylglutaric acid (100 mg/L) in ethanol. Store at 4◦C
or less.
5. 2H3-acetylaspartic acid. Working calibration solution con-
tains 10 μL of 2H3-acetylaspartic acid (100 mg/L) in
ethanol. Store at 4◦C or less.
6. 2H3-propionylglycine. Working calibration solution con-
tains 20 μL of 2H3-propionylglycine (100 mg/L) in
ethanol. Store at 4◦C or less.
7. 2H3-hexanoylglycine. Working calibration solution con-
tains 20 μL of 2H3-hexanoylglycine (100 mg/L) in
ethanol. Store at 4◦C or less.
8. 1,3-15N2-uric acid. Working calibration solution contains
10 μL of 1,3 15N2-uric acid (100 mg/L) in ethanol. Store
at 4◦C or less.
9. 15N2-uracil. Working calibration solution contains 10 μL
of 15N2-uracil (100 mg/L) in water. Store at 4◦C or less.
10. 2H4 thymine. Working calibration solution contains 10 μL
of 2H4 thymine (100 mg/L) in water. Store at 4◦C or less.
11. 15N2-orotic acid. Working calibration solution contains 10
μL of 15N2-orotic acid (100 mg/L) in water. Store at 4◦C
or less.
12. Calibration solutions are prepared in an aqueous matrix to
simulate the composition of urine samples. The aqueous
matrix is composed of the following:
a. 30 mM urea (Sigma-Aldrich).
b. 11.4 mM sodium chloride (Sigma-Aldrich).
c. 7.8 mM potassium chloride (Sigma-Aldrich).
d. 1.5 mM potassium dihydrogen orthophosphate (Sigma-
Aldrich).
e. 7.6 mg/L bovine serum albumin (Sigma-Aldrich).
13. For monitoring recoveries and for quality control purposes,
a pooled urine sample is prepared and diluted to a creati-
nine concentration of 1.0 mM. Two enriched urine samples
are prepared by diluting the same pooled urine sample to a
creatinine concentration of 1.0 mM and adding abnormal
amounts of metabolites.
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2.7. Instruments 1. Dimension RxLMax Integrated Chemistry System (Siemens
Healthcare Diagnostics Inc., Newark, NJ).
2. Gas chromatograph 6890 N with a single-quadrupole mass
spectrometer (5975) as detector (Agilent Technologies, Palo
Alto, CA).
3. 1100 Series Cap Pump HPLC (Agilent Technologies,
Waldbronn, Germany) coupled to an Agilent Micro ALS
Autosampler.
4. API 4000 bench-top triple-quadrupole mass spectrome-
ter equipped with the TurboIonSpray source (AB–Sciex,
Toronto, Canada).
3. Methods
3.1. Sample
Collection
1. Urine samples should be collected over 24 h when possi-
ble. However, considering that prolonged urine collections
are quite difficult, especially for newborns or very young
babies, a random sample, preferably the first morning void-
ing, is acceptable. Thus, it is possible to obtain results simi-
lar to those obtained in a 1-day collection (6), although the
amount of many organic acids, excreted per milligram of cre-
atinine, varies considerably according to age. Newborns and
small babies have not yet developed complete renal tubu-
lar function, so they normally excrete a larger amount of
aliphatic acids.
2. Any urine samples must be accompanied by a form con-
taining information about clinical history, therapy, and diet
details over the last 48 h. This is a critical point for a correct
interpretation of data (see Note 1).
3. Urine should be collected in clean glass containers to avoid
contamination by plastic compounds (e.g., phthalates) (7),
and the containers should be preferably sterile.
4. Collect 24-h urine samples by freezing each single sampling.
Other protein-free physiological fluids should be collected in
the same way (see Note 1). Considering that most patients
are acutely ill, this procedure is almost impractical.
3.2. Storage 1. Analyze urine samples immediately or freeze at –70◦C until
analysis.
2. If a –70◦C freezer is not available, freeze the urine samples at
–20◦C. Indeed, if containers are not sterile, prolonged expo-
sure at room temperature leads to bacterial growth, produc-
tion of artifacts, and the formation of new organic acids (8)
or loss of volatile acids (see Note 1). Urine samples should
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be transported in a deeply frozen state, preferably packed in
solid carbon dioxide at –70◦C.
3. Some authors suggested adding 2 mL of chloroform
or merthiolate [o-(carboxyphenyl)thioethylmercury] sodium
salt to urine sample as a preservative (see Note 1). Merthi-
olate is toxic by inhalation, ingestion, and contact with skin
(EC hazard symbol T+), and it has cumulative effects. It is
also very toxic to aquatic organisms and may cause long-
term adverse effects in aquatic environments. Therefore, the
addition of choloroform or merthiolate as a preservative is
very seldom used.
3.3. Creatinine Assay Creatinine (2-imino-1-methyl-4-imidazolidinone) concentration
is the reference to which each organic acid concentration is
typically normalized for quantitative purposes. However, this
molecule is often declared unsuitable as a reference standard
(8), due to its increasing excretion with age (9) and wide vari-
ation between individuals, especially small babies and newborns
(10). Moreover many differences between males and females
have been reported (9). Thus, the accurate determination of
creatinine prior to urinary organic acid analysis is extremely
important.
The alkaline picrate-based method (a modified Jaffe method)
has been reported to be less susceptible than conventional meth-
ods to interference from non-creatinine Jaffe-positive compounds
(11). Sampling, reagent delivery, mixing, and processing of the
analysis are automatically carried out by the Dimension Chem-
istry System.
1. Add about 100 μL of urine to a cuvette. Creatinine reacts
with picrate (lithium picrate 25 mM) in presence of a strong
base, like sodium hydroxide (NaOH 100 mM), forming a
red chromophore (λ 510 nm). The rate of increasing absorp-
tion is directly proportional to the creatinine concentration
in the sample.
2. Read the value of creatinine. It is measured by using a
bichromatic (absorption wavelengths: λ 510 and λ 600 nm)
rate technique (Dimension Chemistry System or similar) (see
Note 3).
3.4. Oximation 1. Dilute urine sample corresponding to 0.5 or 1 mmol of
creatinine with distilled water to 1,500 mL.
2. Adjust the pH to 14 with 5 M NaOH.
3. Add 0.5 mL of aqueous hydroxylamine solution.
4. Heat the urine and hydroxylamine mixture at 60◦C for
30 min, then cool the solution to room temperature, and
acidify to pH 1 with 6 M HCl.
5. After acidification, proceed with extraction as described
below.
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3.5. Extraction
Procedure
In our experience, samples capped well with silicon caps are sta-
ble about 1 week at 4◦C, prior to the derivatization step (12).
The solvent extraction procedure described below is widely used
even if polar acids are not efficiently extracted. Moreover, many
non-acid compounds are extracted, such as urea and alcohols, and
these compounds can interfere with the chromatographic sep-
aration. Great attention also must be paid to the contaminants
potentially present in the organic extraction solvent (see Note 1).
a. Place a volume of urine corresponding to 0.5 or 1 mmol of
creatinine in a 14 × 100-mm screw-cap culture tube.
b. Dilute the sample with deionized water to 1.5 mL and adjust
the pH to 1 by dropwise addition of 6 M HC1 or 2.5 M
H2SO4.
c. Add internal standards: 10 μL of DMMA (100 mg/L) in
ethanol/water (1:1, v/v); 20 μL of TA (100 mg/L) in
water; and 20 μL of PDA (100 mg/L) in ethanol.
d. Extract the acidified sample three or four times with 2-mL
aliquots of ethyl acetate (or diethyl ether), shaking the tube
vigorously. The extraction efficiency has been measured by
Tanaka and colleagues (13) who reported that hydroxy acids
and low molecular weight dicarboxylic acids were recovered
with much higher yields with ethyl acetate than with diethyl
ether.
e. After shaking, centrifuge the mixture at 1,620×g for 10 min.
f. Combine the organic layers in a second tube (see Note 4)
and then dry the combined extract over about 1–1.5 g of
anhydrous Na2SO4 for 45–60 min.
g. Wash the Na2SO4 twice with 1-mL portions of ethyl acetate.
Optionally, the sample can be filtered with filter paper into a
third tube prior to washing the Na2SO4.
h. Dry the extract under a nitrogen stream at 60◦C. When the
volume is about 1–1.5 mL, transfer the solution to a 2-mL
GC-MS glass vial and dry the remaining solvent.
3.6. Derivatization
Procedures
After extraction procedures, in order to make the acids more
volatile and stable for gas chromatography, a derivatization step
is performed. Most laboratories use trimethylsilylation.
1. Add 50 μL of bis-trimethylsilyl-trifluoroacetamide (BSTFA)
to the evaporated sample in a 2-mL GC-MS glass vial,
vortex-mix, and incubate at 60◦C for 30 min. It is also
possible to use N-methyl-N-trifluoroacetamide (MSTFA),
N,O-bis[trimethylsilyl]acetamide (BSA), or N-methyl-N-
[tert-butyldimethyl-silyl]trifluoroacetimide (MTBSTFA) as
alternative derivatization reagents. All of these agents can be
used at full strength or diluted with a suitable solvent such
as pyridine.
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3.7. Gas Chromatog-
raphy/Mass
Spectrometry
Analysis
1. The vialed samples should be kept at room temperature
until analysis and analyzed no later than 24 h after prepara-
tion.
2. Generally, the GC analyses are performed on a gas chro-
matograph coupled to a single-quadrupole mass spectrom-
eter as analyzer.
3. The capillary column is typically a nonpolar column such
as an HP-5 ms or J&W ULTRA2 or similar.
4. The carrier gas is helium at 1 mL/min.
5. The column oven initial temperature is 70◦C; the temper-
ature gradient is 10◦C/min to 280◦C, followed by 280◦C
for 5 min.
6. The injection volume is 1 μL (see Note 5) with a split ratio
of 10:1, and the front inlet temperature is 280◦C.
7. The detector temperature is typically about 280–300◦C.
8. The mass spectra are recorded both in selected ion moni-
toring (SIM) and in scan mode over a mass range of 40–
550 m/z. A list containing the most characteristic ions and
molecular weights of the main organic acids is reported in
Table 4.2. Table 4.3 contains the most diagnostic acyl-
glycines molecular ions and characteristic fragments.
9. The retention times are obtained using chemical organic
acid standards. Both standards and urine samples are ana-
lyzed under the same chromatographic conditions.
10. Mass calibration (see Note 6) of the instrument by using a
mixture containing the target compounds at different con-
centrations is a critical step. The authors calibrated the mass
spectrometer using a mixture containing about 100 differ-
ent organic acids using a 5-point curve containing 10, 25,
50, 100, and 250 μM of each.
11. The calibration must be performed monthly or more fre-
quently (see Note 6).
12. For quantitation purposes, a mixture containing 50 μM of
standards is analyzed weekly, and if the quantitation report
differs from the expected values by more than 25%, a new
calibration curve is made.
13. The GC-MS system must have a regular maintenance
schedule to avoid artifacts and generation of new com-
pounds in the organic acids profile (see Note 7).
14. Many labs choose to perform a semiquantitative determi-
nation of urinary organic acids using non-labeled inter-
nal standards. These standards are non-physiological com-
pounds that elute in proximity to the organic acids to
be quantified. In our own experience, dimethylmalonic
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Table 4.2
The most characteristic ions and molecular weights of the main organic acids
Characteristic urinary organic acid MW M-15 Ion 1 Ion 2
2-Keto-isovaleric acid (oxime) di-TMS 275 260 232 158
2-Keto-isocaproic acid (oxime) di-TMS 289 274 200 172
2-Keto-3-methylvaleric acid (oxime) di-TMS 289 274 200 172
2-Ketoglutaric acid (oxime) di-TMS 377 362 260
2-Hydroxy-3-methylvaleric acid 276 261 159
2-Hydroxy-adipic acid 378 363
2-Hydroxy-butyric acid di-TMS 248 233 131
2-Hydroxy-glutaric acid 364 349 247 203
2-Hydroxy-isobutyric acid di-TMS 248 233 95
2-Hydroxy-isocaproic acid di-TMS 276 261 159 103
2-Hydroxy-isovaleric acid di-TMS 262 247 219 145
2-Hydroxy-sebacic acid tri-TMS 419 391 317
2-Methyl-3-hydroxy-butyric acid di-TMS 262 247 117
2-Methyl-acetoacetic acid di-TMS 260 245
3-Hydroxy-3-methylglutaric acid 378 363 273 247
3-Hydroxy-adipic acid 378 363 247
3-Hydroxy-butyric acid 248 233 191 117
3-Hydroxy-isobutyric acid 248 233 177 103
3-Hydroxy-decanedioic acid 432 417 233
3-Hydroxy-dodecanedioic acid 462 447 233
3-Hydroxy-dodecanedioic acid 460 445 233
3-Hydroxy-glutaric acid 364 349 259 185
3-Hydroxy-isovaleric acid 262 247 205 131
3-Hydroxy-octanedioic acid 404 389 233 217
3-Hydroxy-propionic acid di-TMS 234 219 204 177
3-Hydroxy-sebacic acid tri-TMS 434 419 233 217
3-Hydroxy-suberic acid tri-TMS 406 391 233 217
3-Hydroxy-tetradecanedioic acid tri-TMS 490 475 233 217
3-Hydroxy-tetradecanedioic acid tri-TMS 488 473 233 217
3-Methylglutaconic acid di-TMS 288 273 198 183
3-Methylglutaric acid di-TMS 290 275 204 69
3,4-Dihydroxy-butyric acid tri-TMS 336 233 189
3,6-Epoxyoctanedioc acid di-TMS 332 317 201 174
3,6-Epoxydecanedioc acid di-TMS 360 345 201 174
3,6-Epoxydodecanedioc acid di-TMS 388 372 201 174
3,6-Epoxytetradecanedioc acid di-TMS 416 401 201 174
4-Hydroxy-butyric acid di-TMS 248 233 204 117
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Table 4.2
(continued)
Characteristic urinary organic acid MW M-15 Ion 1 Ion 2
4-Hydroxy-phenyllactic acid tri-TMS 398 383 308 179
4-Hydroxy-phenylpyruvic acid tri-TMS 396 381 325
4-Hydroxy-phenylpyruvic acid (oxime) tri-TMS 412 396 277 190
4,5-Dihydroxy-hexanoic tri-TMS (erythro and threo) 364 349 247 129
4,5-Dihydroxy-hexanoic lactone (erythro and threo) 202 187 158 143
5-Hydroxy-hexanoic acid di-TMS 276 261 204 171
7-Hydroxy-octanoic acid di-TMS 304 289 260
Adipic acid di-TMS 290 275 172 111
Decanedioic acid di-TMS 344 329 164 119
Dodecanedioic aid 374 359 243
Ethylmalonic acid di-TMS 276 261 217
Fumaric acid di-TMS 260 245 147
Glutaconic acid di-TMS 274 259 217
Glutaric acid di-TMS 276 261 158
Glycerol tri-TMS 308 293 218 205
Glycerol 3-phosphate tetra-TMS 460 445 357 299
Glyceric acid tri-TMS 322 307 292 205
Hydantoin-3-hydroxy-propionic acid tri-TMS 388 373 257 230
Homogentisic acid tri-TMS 384 341 252
Isovaleryl-glutamic acid di-TMS 375 360 258 156
Lactic acid di-TMS 234 219 190 117
Malic acid tri-TMS 350 319 245 233
Malonic acid di-TMS 248 233 133
Mandelic acid di-TMS 296 281 253 179
Methylcitric acid tetra-TMS 494 479 389 361
Methylmalonic acid di-TMS 262 247 218 157
Methylsuccinic acid di-TMS 276 261 217
Mevalonic acid tri-TMS 364 349 247 233
Mevalonic lactone mono-TMS 202 187 145 115
Mevalonic lactone di-TMS 274 259 187 175
N-acetyl-alanine di-TMS 275 260 232 158
N-acetylaspartic acid tri-TMS 391 376 274 230
N-acetylaspartic acid di-TMS 319 304 202 158
N-acetylglutamic di-TMS 333 318 216 158
N-acetyl-isoleucine tri-TMS 245 230 128 86
N-acetyl-methionine di-TMS 335 320 274 261
N-acetyl-serine di-TMS 291 276 261 186
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Table 4.2
(continued)
Characteristic urinary organic acid MW M-15 Ion 1 Ion 2
N-acetyl-valine di-TMS 303 288 260 186
Octanedioic acid di-TMS 316 301 136 137
Orotic acid tri-TMS 372 357 254
Oxalic acid di-TMS 234 219 190
Phenyllactic acid di-TMS 310 295 220 193
Phenylpyruvic acid (oxime) 323 308 189
Pyroglutamic acid di-TMS 273 258 156
Pyruvic acid (oxime) di-TMS 247 232 204
Sebacic acid di-TMS 346 331 345
Suberic acid di-TMS 318 303 169
Succinic acid di-TMS 262 247 172
Succinylacetone (oxime) 227 212 182 138
Tetradecanedioic acid di-TMS 402 387 271
Uracil di-TMS 256 241 99
Vanillactic acid tri-TMS 428 413 338 209
Xanthurenic acid tri-TMS 420 406 318
acid, tropic acid, pentadecanoic acid, tricarballylic acid,
2-oxocaproic acid, and 2-phenylbutyrric acid can be used as
internal standards. Their use is advantageous only in terms
of cost per analysis (see Note 8).
15. Quantitation is performed according to either Internal
Standard Method or the Absolute Calibration Curve
Method, generally using the peak height or peak area.
16. Internal Standard Method
a. Prepare several standard solutions containing a constant
amount of the specified labeled or unlabeled internal
standard and known graded amounts of the compound
to be quantified.
b. With each of the chromatograms obtained by injecting a
constant volume of each standard solution, calculate the
ratio of the peak height or peak area of the compound
to be quantified to that of the internal standard.
c. Prepare a calibration curve by plotting these ratios on
the ordinate and the ratios of each amount of the com-
pound to be quantified to the amount of the internal
standard, or simply the amount of the compound to be
quantified, on the abscissa. The calibration curve is usu-
ally a straight line through the origin.
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Table 4.3
The most diagnostic acylglycines molecular ions and characteristic fragments
Acylglycine mono-TMS
derivatives [M]+ [M-15]+ [M-117]+ [M-146]+ [M-59]+ [M-45]+ [M-44]+
2-Methylbutyrylglycine 231 216 114 85 172 186 187
3-Methylcrotonylglycine 229 214 112 83 170 184 185
Butyrylglycine 217 202 100 71 158 172 173
Hexanoylglycine 245 230 128 99 186 200 201
Isobutyrylglycine 217 202 100 71 158 172 173
Isovalerylglycine 231 216 114 85 172 186 187
Phenylpropionylglycine 270 255 86 57 144 158 159
Propionylglycine 203 188 86 57 144 158 159
Tiglylglycine 229 214 112 83 170 184 185
Suberylglycine 300 285 183 154 241 255 256
Aclglycine di-TMS
derivatives
[M]+ [M-15]+ [M-117]+ [M-131]+ [M-218]+
2-Methylbutyrylglycine 303 288 186 172 85
3-Methylcrotonylglycine 301 286 184 170 83
Butyrylglycine 289 274 172 158 71
Hexanoylglycine 317 302 200 186 99
Isobutyrylglycine 289 274 172 158 71
Isovalerylglycine 303 288 186 172 85
Phenylpropionylglycine 343 328 226 212 125
Propionylglycine 275 260 158 144 57
Tiglylglycine 301 286 184 170 83
Suberylglycine 375 360 256 242 155
[M-15]+=[M-CH3]+
[M-117]+=[M-COOSi(CH3)3]+
[M-146]+=[RCO]+ R=alkyl radical
[M-59]+=[M-CH2COOH]+
[M-45]+=[M-COOH]+
[M-44]+=[M-COO]+
[M-131]+=[M-CH2COOSi(CH3)3]+
[M-218]+=[RCO]+ R=alkyl radical
d. Prepare the urine sample containing the same amount of
the internal standard as directed in the individual mono-
graph.
e. Record a chromatogram under the same conditions as
for the preparation of the calibration curve.
f. Calculate the ratio of the peak height or peak area of
the compound to be quantified to that of the internal
standard.
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g. Perform the quantitation using the calibration curve.
17. Absolute Calibration Curve Method
a. Prepare standard solutions containing a graded amount
of the compound to be quantified and inject a constant
volume of each standard solution.
b. With the chromatograms obtained, prepare a calibra-
tion curve by plotting the peak heights or peak areas
of the compound to be quantified on the ordinate and
the amounts of the compound to be quantified on the
abscissa. The calibration curve is usually a straight line
through the origin.
c. Prepare the urine sample as directed in the individual
monograph.
d. Record a chromatogram under the same conditions used
for the preparation of the calibration curve.
e. Measure the peak height or peak area of the compound
to be quantified.
f. Perform the quantitation using the calibration curve.
3.8. Liquid Chro-
matography/Mass
Spectrometry
Analysis
1. Loop injections (20 μL) are made via a HPLC autosam-
pler into a mobile phase of acetonitrile–water (1:1 by
volume).
2. The mobile phase and sample are infused at a flow
rate of 30 μL/min by an HPLC pumping system into
the electrospray ion source of a triple-quadrupole mass
spectrometer.
3. The ion source operated with a capillary voltage of 5.0 kV
(positive-ion mode) or 4.5 kV (negative-ion mode) and a
temperature of 250◦C. Nitrogen is used as collision gas at
a pressure of 10 mTorr.
4. Fragmentation transitions, declustering potentials, and col-
lision energies should be optimized during manual loop
injections of pure compounds.
5. Negative-ion multiple reaction monitoring (MRM) for 49
metabolites and 11 labeled internal standards is performed
under the conditions shown in Table 4.4.
6. Data are acquired for 1.3 min after injection, and the total
cycle time between injections is 2.1 min.
7. Data are processed with MRM signals averaged between
0.6 and 1.3 min and baseline subtraction of signals from
0.15 to 0.45 min.
8. Raw data are exported to an Excel spreadsheet file
(Microsoft) for calculations.
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Table 4.4
Precursor (Q1), product ion (Q3) masses, and optimized voltages for the 60
compounds studied in negative-ion mode
Metabolites Q1/Q3 transition DP (V) CE (V) Internal standard
1 Glycolic acid 75 > 47 –30 –20 14
2 Lactic acid 89 > 43 –40 –20 14
3 3-Hydroxy-propionic acid 89 > 59 –30 –15 14
4 3-Hydroxy-butyric acid 103 > 59 –30 –15 14
5 4-Hydroxy-butyric acid 103 > 57 –15 –20 14
6 2-Hydroxy-butyric acid 103 > 57 –17 –25 14
7 Glyceric acid 105 > 75 –25 –15 14
8 Fumaric acid 115 > 71 –18 –12 14
9 Maleic acid 115 > 71 –19 –13 14
10 3-Hydroxy-isovaleric acid 117 > 59 –21 –14 15
11 2-Hydroxy-isovaleric acid 117 > 71 –31 –16 14
12 Succinic acid 117 > 73 –12 13 14
13 Methylmalonic acid 117 > 73 –10 –13 14
14 2H3-Methylmalonic acid 120 > 76 –10 –13
15 2H3-3-Hydroxy-isovaleric acid 123 > 59 –21 –15
16 Glutaric acid 131 > 87 –10 –13 28
17 Ethylmalonic acid 131 > 87 –10 –12 28
18 Methylsuccinic acid 131 > 87 –11 –13 28
19 Phosphoethanolamine 140 > 79 –20 –15 28
20 3-Methylglutaconic acid 143 > 99 –5 –9 28
21 2-Ketoglutaric acid 145 > 101 –20 –13 28
22 3-Methylglutaric acid 145 > 101 –22 –16 28
23 Adipic acid 145 > 83 –10 –18 28
24 2-Hydroxy-glutaric acid 147 > 129 –22 –13 28
25 Mevalonic acid 147 > 59 –25 –21 28
26 3-Hydroxy-glutaric acid 147 > 85 –11 –13 31
27 4-Hydroxy-phenylacetic acid 151 > 107 –8 –20 28
28 13C6-Adipic acid 151 > 88 –10 –18
29 Succinylacetone 157 > 99 –10 –12 46
30 3-Hydroxy-3-methylglutaric acid 161 > 99 –13 –14 31
31 2H3-3-Hydroxy-3-methylglutaric acid 164 > 102 –13 –14
32 Homogentisic acid 167 > 123 –34 –15 28
33 Suberic acid 173 > 111 –31 –18 28
34 N-acetylaspartic acid 174 > 88 –17 –19 35
35 2H3-acetylaspartic acid 177 > 89 –17 –19
36 Homovanillic acid 181 > 137 –19 –13 28
37 4-Hydroxy-phenyllactic acid 181 > 163 –30 –16 28
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Table 4.4
(continued)
Metabolites Q1/Q3 transition DP (V) CE (V) Internal standard
38 Sulfocysteine 200 > 136 –30 –14 28
39 Sialic acid 308 > 87 –33 –23 28
40 Uracil 111 > 42 –20 –20 41
41 15N2-uracil 113 > 43 –17 –20
42 Thymine 125 > 42 –22 –31 43
43 Thymine D4 129 > 42 –20 –31
44 Xanthine 151 > 108 –27 –25 48
45 Orotic acid 155 > 111 –13 –13 46
46 15N2-orotic acid 157 > 113 –13 –15
47 Uric acid 167 > 124 –54 –25 48
48 1,3 15N2-uric acid 169 > 125 –54 –25
49 Propionylglycine 130 > 74 –30 –13 50
50 2H3-propionylglycine 133 > 74 –30 –13
51 Butyrylglycine 144 > 74 –45 –15 50
52 Isobutyrylglycine 144 > 74 –45 –15 50
53 3-Methylcrotony lglycine 156 > 74 –45 –15 50
54 Tiglylglycine 156 > 75 –45 –15 50
55 Methylbutyry lglycine 158 > 74 –45 –15
56 Isovalerylglycine 158 > 74 –50 –15 58
57 Hexanoylglycine 172 > 74 –45 –15 58
58 2H3-hexanoylglycine 175 > 74 –45 –15
59 3-Phenylpropiony lglycine 206 > 74 –45 –15 58
60 Suberylglycine 230 > 74 –45 –15 58
9. Ratios of the MRM signals of the metabolites relative to
the internal standards are used to construct calibration
curves and calculate concentrations in the urine samples.
The internal standards used for each metabolite are listed
in Table 4.4.
10. Six calibrators with concentrations 0 (i.e., blank), 10, 25,
50, 100, and 250 μM are run with every batch of sam-
ples. The unenriched and enriched urine samples are also
included with each batch.
11. Imprecision and analytical recovery from the enriched
urine samples are determined from consecutive batches
run over a period of 5 weeks. The presence of salts in
the urine can lead to significant suppression of negative-
ion signals, which in turn affects the linearity, inter-batch
variability, and recovery for metabolites quantified with-
out their corresponding labeled internal standards. This ion
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Table 4.5
Isobaric interferences in negative ionization mode
Metabolites Q1/Q3 transition
4-Hydroxy-butyric acid 103 > 57
2-Hydroxy-butyric acid 103 > 57
Succinic acid 117 > 73
Methylmalonic acid 117 > 73
Glutaric acid 131 > 87
Ethylmalonic acid 131 > 87
Methylsuccinic acid 131 > 87
Butyrylglycine 144 > 74
Isobutyrylglycine 144 > 74
2-Ketoglutaric acid 145 > 101
3-Methylglutaric acid 145 > 101
Tiglylglycine 156 > 74
3-Methylcrotonylglycine 156 > 74
Isovalerylglycine 158 > 74
Methylbutyrylglycine 158 > 74
suppression effect is minimized using several labeled inter-
nal standards. Apart from routine ion source cleaning per-
formed at approximately weekly intervals, no other precau-
tions are taken to minimize ion source contamination.
12. A careful selection of appropriate MRM transitions makes
it possible to measure several isomeric metabolites. In some
cases, no suitable transitions to solve isomeric compounds
are found (Table 4.5) (5). This condition can be solved in
the future by coupling the tandem mass spectrometer with
HPLC separation.
13. The primary application of the LC tandem mass spectrom-
eter urine screening method is as a first test for suspected
inborn errors of metabolism. While the tandem mass spec-
trometry method can be used to test all urine samples, GC-
MS-based organic acid analysis is typically used to confirm
abnormal LC tandem mass spectrometer results or to dis-
tinguish isomers.
4. Notes
1. The 24-h collected urine should be considered a first choice
for the analysis of organic acids. The majority of patients with
suspicion of IEM are in neonatal age; thus, it is important to
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perform a rapid test, preferably on the first morning voiding.
When possible, urine samples must be stored in a freezer
at –20◦C if a –70◦C system is not available. In fact, poor
preservation of samples can lead to (1) bacterial conversion
of some organic acids to artifacts such as the conversion of
all keto acids to their respective hydroxy acids, (2) increased
levels of succinic acid from bacterial degradation of glu-
tamine, and (3) an abnormal concentration of pyroglutamic
acid due to conversion from glutamine. The concentration
of such volatile compounds as small molecule organic acids
(e.g. short-chain organic acids) can be shortened if the sam-
ple is exposed to high temperature (especially in summer).
The administration of drugs should be suspended in patients
undergoing organic acids analysis to avoid artifacts due to
drugs or drug metabolism. The following are some examples
of the interference of drugs on the analysis of organic acids.
Valproic acid administration causes an abnormal excretion
of 3-hydroxy-isovaleric acid, tiglylglycine, dicarboxylic acids
(even saturated, e.g., suberic, adipic, and sebacid acids), 2-
methylbutyrylglycine, 7-hydroxy-octanoic acid, 5-hydroxy-
hexanoic acid, and hexanoylglycine. An increase of pivalic
acid can be due to the administration of the antibiotics
pivampicillin and pivmecillinam. Fluvoxamine maleate, a
selective serotonin reuptake inhibitor (SSRI) used to treat
obsessive–compulsive disorder and depression, can cause an
increment of maleic acid. A therapy with the antihyper-
uricemic drug allopurinol can increase orotate urinary excre-
tion. Artifactual formation of new compounds during sam-
ple preparation can also occur. For example, during extrac-
tion with ethyl acetate, decarboxylation of keto acids can
occur (14). Additionally, it is essential to pay attention to sol-
vent contaminants, plasticizers (phthalate, adipate, and seba-
cate esters), glassware-cleaning agents, lubricants, resins, and
bleeding from the stationary phase of the chromatographic
columns.
2. IS work solution stability is only at 4◦C or below. For exam-
ple, the peak intensity of PDA-TMS is considerably larger
when analyzed 1 week after preparation and storage at room
temperature than when immediately analyzed. This is due to
solvent evaporation at room temperature (12).
3. Bilirubine, a potential interferent, is oxidized by using potas-
sium ferricyanide K3Fe(CN)6 at 0.13 mmol/L.
4. Do not mix organic and aqueous phases during liquid/liquid
extraction of urine with solvents.
5. Clean the injector syringe everyday to avoid encrustation,
purging, and bleeding.
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6. Incorrect mass spectrometer calibration can result in abnor-
mal qualitative and quantitative results.
7. Clean the mass spectrometer source and change the liner
every 500 samples. Contamination is usually identified by
an abnormal background. In a GC-MS instrument, there
are sources of contamination within the gas chromatograph
(bleeding septa, dirty injection port liners, air leaks, etc.) and
the mass spectrometer (ion source leaks, fluid/oil, manifold
dirt). Unfortunately, not all contamination can be removed
through running clean carrier gas overnight. When this is
the case, the instrument may need extensive cleaning. Clean-
ing the mass spectrometer ion source to remove contamina-
tion is critical to restore the electrostatic properties of the
ion source lens. The authors suggest that the ion source be
cleaned every 500 runs. Another common source of mass
spectrometer contamination is from inadequate venting and
maintenance of the diffusion pump. Preventive maintenance
ensures that diffusion pump oil/fluids are topped to the cor-
rect levels. It is important to maintain proper fluid levels
to avoid pump failure and ensure optimum performance of
the vacuum system. Air leaks can occur if a seal becomes
damaged or is not correctly fastened. This is another
common problem for any instruments that use a vacuum
and can be identified by a higher than normal vacuum
manifold pressure, low relative ion abundance, and poor
sensitivity.
8. The use of labeled internal standards and isotope dilution
allows one to obtain a correct and absolute quantitation of
organic acids, but it can be very expensive.
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